Ron Bentsur - 06 Jan 2026 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ron Bentsur
Issuer symbol: NVCT
Transactions as of: 06 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2026, 16:31:39 UTC
Previous filing: 06 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BENTSUR RON	Chairman & CEO, Director, 10%+ Owner	C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275, FORT LEE	/s/ Ron Bentsur	09 Jan 2026	0001251213

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Award	$0	+150,000	+4.3%	$0.000000	3,675,924	06 Jan 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates.
F2	Includes shares of restricted common stock.